Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?

Abstract

Background

Chemical-shift magnetic resonance imaging (MRI) has been known to successfully differentiate adenomas from metastases. However, there has been concern that metastasis from extra-adrenal primary malignancies which contain high lipid content such as clear cell renal cell carcinoma (RCC) could mimic adrenal adenomas.

Purpose

To evaluate the ability of MR to differentiate adrenal adenoma from metastasis using chemical-shift imaging and MR feature analysis in patients with clear cell RCC.

Material and Methods

This study was institutional review board-approved; informed consent was waived. Eleven patients with 13 metastases and 13 patients with 15 adrenal adenomas in patients with clear cell RCC for evaluation of an adrenal mass underwent MR. Signal intensity on in- and opposed-phases, signal intensity index (SII), size, T2 SI, cystic change, necrosis, and hemorrhage were evaluated. Statistical analyses included Student t-test and Fisher exact test. If available, precontrast CT attenuation of the adrenal adenomas was measured. SII was correlated with attenuation using Pearson correlation coefficient.

Results

Mean size of adenomas was smaller than that of metastases (P < 0.002). Mean SII of adenomas (45.0% ± 24.6) was significantly greater than that of metastases (6.6% ± 4.7; P < 0.001). With a threshold of 16.5% for SII, the sensitivity, specificity, and accuracy for adenomas were 80%, 100%, and 89.2%, respectively. All six lipid-rich adenomas were diagnosed as adrenal adenoma. Three of eight (37.5%) lipid-poor adenomas were misdiagnosed as metastases. While up to 53.8% (7/13) of the metastases demonstrated cystic change, necrosis, or hemorrhage, only one (6.7%) adenoma exhibited cystic change or necrosis (P < 0.05 for all). Precontrast attenuation and SII were significantly correlated: r = –0.810 (P < 0.001).

Conclusion

In patients with clear cell RCC who underwent MR for adrenal masses, SII and MR features such as cystic change, necrosis, and hemorrhage were helpful in differentiating adenomas from metastases.

Keywords

Adrenal MRI adenoma metastases chemical shift

Get full access to this article

View all access options for this article.

References

Reinig

Stutley

Leonhardt

. Differentiation of adrenal masses with MR imaging: Comparison of techniques. Radiology 1994; 192: 41–46.

Mayo-Smith

Lee

McNicholas

. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: Observer performance versus quantitative measures. Am J Roentgenol 1995; 165: 91–95.

Savci

Yazici

Sahin

. Value of chemical shift subtraction MRI in characterization of adrenal masses. Am J Roentgenol 2006; 186: 130–135.

Leroy-Willig

Bittoun

Luton

. In vivo MR spectroscopic imaging of the adrenal glands: Distinction between adenomas and carcinomas larger than 15 mm based on lipid content. Am J Roentgenol 1989; 153: 771–773.

Shinozaki

Yoshimitsu

Honda

. Metastatic adrenal tumor from clear-cell renal cell carcinoma: A pitfall of chemical shift MR imaging. Abdom Imaging 2001; 26: 439–442.

Caoili

Korobkin

Francis

. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222: 629–633.

Inan

Arslan

Akansel

. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur Radiol 2008; 65: 154–162.

Choi

Kim

Park

. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: Use of delayed contrast-enhanceded CT. Radiology 2013; 266: 514–520.

McNicholas

Lee

Mayo-Smith

. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. Am J Roentgenol 1995; 165: 1453–1459.

10.

Haider

Ghai

Jhaveri

. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: Does it still have a role? Radiology 2004; 231: 711–716.

11.

Delfaut

Beltran

Johnson

. Fat suppression in MR imaging: Techniques and pitfalls. Radiographics 1999; 19: 373–382.

12.

Fujiyoshi

Nakajo

Fukukura

. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. Am J Roentgenol 2003; 180: 1649–1657.

13.

Park

Kim

. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 2007; 243: 760–765.

14.

Boland

Lee

Gazelle

. Characterization of adrenal masses using unenhanced ct: An analysis of the ct literature. Am J Roentgenol 1998; 171: 201–204.

15.

Hindman

Ngo

Genega

. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 2012; 265: 468–477.

16.

Heinz-Peer

Honigschnabl

Schneider

. Characterization of adrenal masses using MR imaging with histopathologic correlation. Am J Roentgenol 1999; 173: 15–22.

17.

Glazer

Woolsey

Borrello

. Adrenal tissue characterization using MR imaging. Radiology 1986; 158: 73–79.

18.

Maurea

Imbriaco

D'Angelillo

. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions. Radiol Med 2006; 111: 674–686.

19.

Outwater

Siegelman

Huang

. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996; 200: 749–752.

20.

Pena

Boland

Hahn

. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217: 798–802.

21.

Mitchell

Crovello

Matteucci

. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185: 345–351.

22.

Remer

Weinfeld

Glazer

. Hyperfunctioning and nonhyperfunctioning benign adrenal cortical lesions: characterization and comparison with MR imaging. Radiology 1989; 171: 681–685.

23.

Gufler

Eichner

Grossmann

. Differentiation of adrenal adenomas from metastases with unenhanced computed tomography. J Comput Assist Tomogr 2004; 28: 818–822.

24.

Boland

Blake

Hahn

. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008; 249: 756–775.

25.

Boland

. Adrenal imaging: why, when, what, and how? Part 1.. Why and when to image? Am J Roentgenol 2010; 195: W377–W381.

26.

Korobkin

Brodeur

Francis

. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. Am J Roentgenol 1998; 170: 747–752.

27.

Caoili

Korobkin

Francis

. Delayed enhanced CT of lipid-poor adrenal adenomas. Am J Roentgenol 2000; 175: 1411–1415.

28.

Bilbey

McLoughlin

Kurkjian

. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. Am J Roentgenol 1995; 164: 637–642.

29.

Halefoglu

Altun

Disli

. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases. J Comput Assist Tomogr 2012; 36: 367–374.

30.

Schindera

Soher

Delong

. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology 2008; 248: 140–147.

31.

Israel

Korobkin

Wang

. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. Am J Roentgenol 2004; 183: 215–219.